Phase III Trial of Eprotirome: Discontinued for Safety Concerns

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.26, Iss.3, 2012-06, pp. : 185-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase III ATENA Trial of Exemestane Discontinued

By Sweetlove Mel

Pharmaceutical Medicine, Vol. 26, Iss. 1, 2012-02 ,pp. : 45-47

Adis International

Access to resources Recommend Favorite

Phase III Trial of Dalcetrapib: Discontinued Due to Lack of Efficacy

By Sweetlove Mel

Pharmaceutical Medicine, Vol. 26, Iss. 4, 2012-08 ,pp. : 253-256

Adis International

Access to resources Recommend Favorite

Phase III Trial of Lapatinib: Discontinued due to Inferior Efficacy

Pharmaceutical Medicine, Vol. 26, Iss. 5, 2012-10 ,pp. : 321-325

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK) has discontinued enrolment into its phase III trial of the HIV entry inhibitor, aplaviroc [GW 873140]

Reactions Weekly, Vol. 1, Iss. 1076, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A Randomized, Placebo-Controlled, Double-Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint

By William Hanke C. Narins Rhoda S. Brandt Fredric Cohen Joel L. Donofrio Lisa M. Downie Jeanine Heinz Moritz Harrington Laura McDaniel David H. Nestor Mark Schlessinger Joel Schlöbe Andrea Taub Amy Weiss Robert A.

Dermatologic Surgery, Vol. 39, Iss. 6, 2013-06 ,pp. : 891-899

Elsevier

Access to resources Recommend Favorite